Researchers at Stanford Medicine have identified a promising strategy to safeguard brain cells in a hereditary form of Parkinson’s disease. In experiments involving mice, they discovered that inhibiting an overactive enzyme allowed damaged neurons to re-establish communication and showed early signs of recovery. This study was published in the journal Science Signaling.
Parkinson’s disease is a progressive brain disorder characterized by a gradual decline in motor skills. It manifests through symptoms such as tremors, muscle rigidity, slowed movements, and balance issues. These symptoms result from the progressive loss of dopamine-producing neurons, which are crucial for transmitting signals within the brain. As these neurons deteriorate, functions like movement, motivation, learning, and decision-making become impaired.
In some cases, Parkinson’s is linked to mutations in the LRRK2 gene. These genetic changes cause the associated enzyme to become excessively active, disrupting normal communication between brain cells and accelerating neuronal damage. The Stanford team focused on a compound called MLi-2, which inhibits LRRK2 activity. They hypothesized that turning off this overactive enzyme could enable damaged neurons to recover and restore their signaling capabilities.
Central to healthy brain function are tiny structures known as primary cilia, acting like cellular antennas. These cilia detect and transmit chemical messages vital for cell survival. When LRRK2 enzyme activity is heightened, many neurons lose their primary cilia, impairing their ability to receive signals that promote survival. A key message suppressed in this process involves sonic hedgehog, a protein that instructs neighboring cells to produce protective substances supporting dopamine neurons. Without primary cilia, these protective signals cannot reach the neurons, increasing their vulnerability.
Initially, mice received a two-week course of MLi-2, but the effects were modest. Extending the treatment to three months yielded significantly better results. During this extended period, primary cilia reformed on critical brain cells, and communication between brain regions was largely restored. The activation of protective signaling pathways resumed, and evidence emerged that damaged dopamine neurons began to recover.
Dr. Suzanne Pfeffer, the senior author of the study, noted that early intervention with LRRK2 inhibitors could potentially slow or delay Parkinson’s progression. The earliest symptoms, such as loss of smell, constipation, and sleep disturbances, can appear years before movement issues become evident. Ongoing clinical trials of LRRK2 inhibitors provide hope that these findings could translate into more effective treatments for patients.
For those interested in Parkinson’s disease, recent research suggests that vitamin B supplements may slow cognitive decline, and adopting a Mediterranean diet could reduce disease risk. Additional studies explore how wheat gluten might influence brain health and how daily consumption of olive oil could support cognitive function.
© 2026 Knowridge Science Report. All rights reserved.
